Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2014
06/24/2014US8759347 Inhibitors of C-FMS kinase
06/24/2014US8759345 Benzoimidazoles as prolyl hydroxylase inhibitors
06/24/2014US8759338 Heterocyclic kinase inhibitors
06/24/2014US8759332 Hepatitis C virus inhibitors
06/24/2014US8759331 X-ray and gamma-photon activable organic compounds, their preparation and their uses
06/24/2014US8758905 Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same
06/19/2014WO2014093353A1 Organic light emitting polyaromatic and polyheteroaromatic host materials
06/19/2014WO2014093230A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
06/19/2014WO2014092483A1 Organic compound and organic electroluminescent element comprising same
06/19/2014WO2014092481A1 Organic compound, and organic electroluminescence device comprising same
06/19/2014WO2014092478A1 Organic compound, and organic electroluminescence device comprising same
06/19/2014WO2014092431A1 Novel compound, and organic electroluminescent device comprising same
06/19/2014WO2014092351A1 Novel organic compound and organic electroluminescent element comprising same
06/19/2014WO2014091415A1 Indole carboxamide derivatives as p2x7 receptor antagonists
06/19/2014WO2014091265A1 Pyrimidine-2,4-diamine derivatives as kinase inhibitors
06/19/2014WO2014090709A1 Dimeric compounds
06/19/2014WO2014090398A1 Use of maleimide derivatives for preventing and treating leukemia
06/19/2014WO2014090396A2 Use of maleimide derivatives for preventing and treating cancer
06/19/2014WO2013134353A8 Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor
06/19/2014US20140171476 Chemical Compounds
06/19/2014US20140171443 Monohydrate Crystalline Form of 3-(5-(4-(3-Fluoropropyl)-Piperazin-1-YL)Benzimidazol-2-YL)-1-Azaazulen-2-One, Preparation, and Pharmaceutical Composition Thereof
06/19/2014US20140171439 Inhibitors Of Histone Deacetylase
06/19/2014US20140171432 Histone demethylase inhibitors
06/19/2014US20140171431 Azole heterocyclic compound, preparation method, pharmaceutical composition and use
06/19/2014US20140171420 Diazole lactams
06/19/2014US20140171419 Enhancement of cellular transplantation using small molecule modulators hepatocyte growth factor (scatter factor) activity
06/19/2014US20140171404 Autotaxin inhibitors
06/19/2014US20140171403 Autotaxin inhibitors
06/19/2014US20140171402 Azetidine derivative and antidepressant composition including the same
06/19/2014US20140171363 Bicyclic acetyl-coa carboxylase inhibitors and uses thereof
06/19/2014US20140170111 Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
06/18/2014EP2743267A1 Dental materials based on polymerisable azides and alkenes
06/18/2014EP2743266A2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon
06/18/2014EP2742040A1 Indazole compounds, compositions and methods of use
06/18/2014EP2742039A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
06/18/2014EP2742030A1 1,2,4-triazolyl-substituted keto-enols
06/18/2014EP2742026A1 Sweet flavor modifier
06/18/2014EP2741746A1 Chemical compounds
06/18/2014CN103874696A Quinazoline derivatives as kinases inhibitors and methods of use thereof
06/18/2014CN103874690A Hydrazide containing nuclear transport modulators and uses thereof
06/18/2014CN103865525A Organic electroluminescence compound
06/18/2014CN103865521A Blue phosphorescence compound and organic light emitting diode comprising the same
06/18/2014CN103864770A Pyrimidinamine and pyridinamine Hedgehog signal conduction inhibitors
06/18/2014CN103864766A Compound for organic optoelectronic device, organic light emitting diode, and display
06/18/2014CN103864765A Benzoazepine derivative containing five-membered heterocycle as well as preparation method and application of derivative
06/18/2014CN103864764A Indazole-substituted pyrimidinamine derivative, and preparation method and use thereof
06/18/2014CN103864763A Monohydrate Crystalline Form of 3-(5-(4-(3-Fluoropropyl)-Piperazin-1-YL)Benzimidazol-2-YL)-1-Azaazulen-2-One, Preparation, and Pharmaceutical Composition Thereof
06/18/2014CN102627632B Amino quinazoline derivative and preparation method as well as application thereof
06/18/2014CN102471319B Inhibitors of JNK
06/18/2014CN102471312B 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
06/18/2014CN102448955B Amino pyrimidine anticancer compounds
06/18/2014CN102307870B Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease
06/18/2014CN102216280B Bisarylurea derivatives and their use
06/18/2014CN102112445B Hydroxyphenylsulfonamides as antiapoptotic Bcl inhibitors
06/18/2014CN101987848B New dihydroindolone derivatives, method of preparing same and pharmaceutical compositions containing the same
06/18/2014CN101952275B Modulators for amyloid protein beta
06/18/2014CN101890018B Tyrosine protein kinase inhibitor and preparation method thereof
06/18/2014CN101535301B Modulators of chemokine receptor activity, crystalline forms and process
06/17/2014US8754239 Process for preparing eletriptan hydrobromide having α-form
06/17/2014US8754211 Azolotriazinone melanin concentrating hormone receptor-1 antagonists
06/17/2014US8754209 Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
06/17/2014US8754084 Therapeutic methods and agents for treating myotonic dystrophy
06/17/2014CA2699986C Anti-infective pyrimidines and uses thereof
06/17/2014CA2626028C Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders
06/17/2014CA2601979C 2,3 substituted pyrazine sulfonamides
06/12/2014WO2014089226A1 Antibacterial compounds targeting isoprenoid biosynthesis
06/12/2014WO2014088519A1 Compounds including map kinase interacting kinases 1 and 2 (mnk1 and mnk2) modulators and abl and abl (t315i) inhibitors, and uses thereof
06/12/2014WO2014088352A1 Organic electroluminescent compounds and organic electroluminescent device comprising the same
06/12/2014WO2014088315A1 Crystalline doripenem monohydrate, and method for preparing same
06/12/2014WO2014088300A1 Organic electroluminescence compounds and organic electroluminescence device comprising the same
06/12/2014WO2014088290A1 Organic electroluminescent compounds and organic electroluminescent device comprising the same
06/12/2014WO2014087657A1 Aromatic amine derivative and organic electroluminescent element
06/12/2014WO2014086894A1 Modulators of the retinoid-related orphan receptor gamma (ror-gamma) for use in the treatment of autoimmune and inflammatory diseases
06/12/2014WO2014086807A1 Novel pyrazine derivatives as cb2 receptor agonists
06/12/2014WO2014086739A1 Novel benzimidazole derivatives as ep4 antagonists
06/12/2014WO2014086737A1 Condensed 2-pyridone-3-carboxamides and the use thereof as herbicides
06/12/2014WO2014086712A1 New indanyloxydihydrobenzofuranylacetic acids
06/12/2014WO2014086663A1 Substituted triazole and imidazole compounds
06/12/2014WO2014086499A1 Neurotensin receptor ligands
06/12/2014WO2014086284A1 Deuterated 3-cyano quinoline compound, pharmaceutical composition, preparation method and use thereof
06/12/2014WO2014086102A1 Indole full ketone derivative used as tyrosine-kinase inhibitor
06/12/2014WO2014047662A3 Indazole derivatives and uses thereof
06/12/2014US20140163231 Hepatitis C Virus Inhibitors
06/12/2014US20140163050 Use of 1H-quinazoline-2,4-diones
06/12/2014US20140163032 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht 2a serotonin receptor useful for the treatment of disorders related thereto
06/12/2014US20140163013 Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
06/12/2014US20140162999 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof
06/12/2014US20140162997 Substituted pyrazoles as n-type calcium channel blockers
06/12/2014US20140162984 Phosphonoxy quinazoline derivatives and their pharmaceutical use
06/12/2014US20140162983 Compositions and Methods for the Production of Pyrimidine and Pyridine Compounds with BTK Inhibitory Activity
06/12/2014US20140162874 Pesticidal compositions and processes related thereto
06/12/2014US20140162361 Pyrimidine cyclohexyl glucocorticoid receptor modulators
06/12/2014US20140161801 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
06/11/2014EP2740729A1 Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament
06/11/2014EP2740726A1 Neurotensin receptor ligands
06/11/2014EP2739618A1 Quinazoline compounds as serine/threonine kinase inhibitors
06/11/2014EP2739615A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
06/11/2014CN103857680A Novel organic electroluminescent compounds and organic electroluminescent device using the same
06/11/2014CN103857675A Metalloenzyme inhibitor compounds
06/11/2014CN103857673A Novel organic electroluminescent compounds and organic electroluminescent device using the same
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 626